Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

New models predict male pattern baldness better than old ones but still need improvement.

BMP4-related anomalies can cause a wide range of eye, brain, and hand/foot problems, and new cases show this variability.

Certain metabolites can either protect against or increase the risk of hair loss.

The DNMT3B -579G>T polymorphism may increase the risk of colorectal cancer.

Higher basal metabolic rate increases the risk of non-alcoholic fatty liver disease, especially in Chinese people, and may require tailored management.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Low-dose oral minoxidil effectively promotes hair growth but has associated risks.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

The new method combining dermoscopy and Reflectance Confocal Microscopy is more effective for evaluating vitiligo.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Machine learning can accurately predict Polycystic Ovary Syndrome in women using clinical features.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

H1 increases risk for neurodegenerative diseases, while H2 offers protection but is linked to other disorders.

Oligomenorrhea is the strongest predictor of PCOS severity.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.